To investigate whether mutant IDH1 could enhance the susceptibility of glioma cells to VSVΔ51, we orthotopically transplanted GL261-TRE-IDH1(R132H) cells into immunocompetent mice (Fig. 6e). This evidence concerns the gene IDH1 and glioma.